A winning approach to biotech

Livewire Exclusive

Livewire Markets

Horizon 3 Biotech is an AU$100m venture capital fund investing to improve lives globally through investments in public and private later-stage companies targeting a return of more than 20% IRR per annum. 

Our ‘Achilles Heel’ approach limits the downside and increases the upside through rigorous due diligence and instinct. We preserve capital by investing in later opportunities closer to exit. 

Biotech is booming and outperforms. If you are looking to diversify your portfolio and achieve outstanding returns in one of the world's highest growth areas, visit our website for more information.

Livewire Exclusive brings you exclusive content from a wide range of leading fund managers and investment professionals.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.